应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
09633 农夫山泉
午间休市 07-29 12:05:00
45.040
+3.180
+7.60%
最高
45.180
最低
42.040
成交量
1,247万
今开
42.040
昨收
41.860
日振幅
7.50%
总市值
5,065亿
流通市值
2,268亿
总股本
112.46亿
成交额
5.57亿
换手率
0.25%
流通股本
50.35亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
异动解读 | 机构看好叠加估值修复,农夫山泉盘中大涨5.06%
异动解读 · 09:46
异动解读 | 机构看好叠加估值修复,农夫山泉盘中大涨5.06%
异动解读|农夫山泉盘中上涨3.06%,美银证券列为中国饮料行业首选股提振延续
行情直击 · 09:40
异动解读|农夫山泉盘中上涨3.06%,美银证券列为中国饮料行业首选股提振延续
异动解读|农夫山泉盘中上涨3.12%,获美银证券列为中国饮料行业首选股
行情直击 · 07-28 10:12
异动解读|农夫山泉盘中上涨3.12%,获美银证券列为中国饮料行业首选股
每周股票复盘:万泰生物(603392)RSV疫苗临床试验获受理
证券之星 · 07-26
每周股票复盘:万泰生物(603392)RSV疫苗临床试验获受理
万泰生物:目前公司疫苗已在全国31个省级政府官方预约平台上线
证券日报网 · 07-23
万泰生物:目前公司疫苗已在全国31个省级政府官方预约平台上线
美银证券:中国饮料业成本压力缓解 但增长阻力犹存 农夫山泉(09633.HK)为首选
智通财经 · 07-23
美银证券:中国饮料业成本压力缓解 但增长阻力犹存 农夫山泉(09633.HK)为首选
农夫山泉(09633)跌超4.6% 美银料中国饮料业增长压力仍存
金吾财讯 · 07-23
农夫山泉(09633)跌超4.6% 美银料中国饮料业增长压力仍存
港股早盘持续发力 恒指半日涨1.34% 中国铝业(02600)升7.02%
金吾财讯 · 07-23
港股早盘持续发力 恒指半日涨1.34% 中国铝业(02600)升7.02%
万泰生物(603392)新增【肝炎】概念
证券之星 · 07-22
万泰生物(603392)新增【肝炎】概念
万泰生物(603392)披露冻干重组呼吸道合胞病毒疫苗临床试验申请获受理公告,7月20日股价上涨2.42%
证券之星 · 07-20
万泰生物(603392)披露冻干重组呼吸道合胞病毒疫苗临床试验申请获受理公告,7月20日股价上涨2.42%
万泰生物荣获证券之星负责任供应链奖
证券之星 · 07-20
万泰生物荣获证券之星负责任供应链奖
股市必读:万泰生物(603392)7月17日董秘有最新回复
证券之星 · 07-20
股市必读:万泰生物(603392)7月17日董秘有最新回复
每周股票复盘:万泰生物(603392)上半年净利预亏1.16亿至1.4亿元
证券之星 · 07-19
每周股票复盘:万泰生物(603392)上半年净利预亏1.16亿至1.4亿元
开塞露配东方树叶可减重8斤?农夫山泉官方客服:没有这个喝法,别乱喝!
新浪财经 · 07-18
开塞露配东方树叶可减重8斤?农夫山泉官方客服:没有这个喝法,别乱喝!
万泰生物:由股东以个人资金自发设立扶助基金属于股东自主公益行为
证券之星 · 07-17
万泰生物:由股东以个人资金自发设立扶助基金属于股东自主公益行为
万泰生物:该方案存在多项合规约束
证券之星 · 07-17
万泰生物:该方案存在多项合规约束
万泰生物:公司与关联方进行业务边界划分
证券之星 · 07-17
万泰生物:公司与关联方进行业务边界划分
万泰生物:统筹研究股权激励相关安排
证券之星 · 07-17
万泰生物:统筹研究股权激励相关安排
万泰生物:后续将策划适配的宣传与公益科普活动
证券之星 · 07-17
万泰生物:后续将策划适配的宣传与公益科普活动
万泰生物:董事长代行总经理、董事会秘书职责
证券之星 · 07-17
万泰生物:董事长代行总经理、董事会秘书职责
加载更多
公司概况
公司名称:
农夫山泉
所属市场:
SEHK
上市日期:
--
主营业务:
农夫山泉股份有限公司是一家主要从事生产及销售包装饮用水及饮料的中国公司。该公司通过五个分部运营。水类产品分部从事制造及销售天然包装饮用水。即饮茶类产品分部从事制造及销售即饮茶。功能饮料产品分部从事制造及销售功能饮料。果汁饮料产品分部从事制造及销售果汁饮料产品。其他产品分部从事制造及销售农产品及其他饮料。该公司主要在国内市场开展其业务。
发行价格:
--
{"stockData":{"symbol":"09633","market":"HK","secType":"STK","nameCN":"农夫山泉","latestPrice":45.04,"timestamp":1785297900009,"preClose":41.86,"halted":0,"volume":12466945,"delay":0,"changeRate":0.07596751075011944,"floatShares":5034666400,"shares":11246000000,"eps":1.6340964328852217,"marketStatus":"午间休市","change":3.18,"latestTime":"07-29 12:05:00","open":42.04,"high":45.18,"low":42.04,"amount":556728008,"amplitude":0.075012,"askPrice":45.06,"askSize":13000,"bidPrice":45.02,"bidSize":9000,"shortable":3,"etf":0,"ttmEps":1.633522009192301,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1785301200000},"marketStatusCode":3,"adr":0,"listingDate":1599494400000,"exchange":"SEHK","adjPreClose":41.86,"dividendRate":0.025093,"openAndCloseTimeList":[[1785288600000,1785297600000],[1785301200000,1785312000000]],"volumeRatio":2.897643,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"NFU.HK","impliedVol":0.485,"impliedVolPercentile":0.9918},"requestUrl":"/m/hq/s/09633","defaultTab":"news","newsList":[{"id":"1174198663","title":"异动解读 | 机构看好叠加估值修复,农夫山泉盘中大涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=1174198663","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174198663?lang=zh_cn&edition=full","pubTime":"2026-07-29 09:46","pubTimestamp":1785289593,"startTime":"0","endTime":"0","summary":"农夫山泉(09633)今日盘中大涨5.06%,引发市场关注。消息面上,美银证券近日发布研报,将农夫山泉列为中国饮料行业首选股,指出尽管PET塑料价格同比仍上涨约20%且行业竞争加剧,但公司拥有稳健的营收增长前景及具韧性的利润率表现。此外,中信建投此前亦维持公司\"增持\"评级,预计公司未来三年净利润分别同比增长16.59%、14.16%及13.07%。多家机构集体看好,叠加估值回调后性价比凸显,推动股价延续上涨势头。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["09633"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149656069","title":"异动解读|农夫山泉盘中上涨3.06%,美银证券列为中国饮料行业首选股提振延续","url":"https://stock-news.laohu8.com/highlight/detail?id=1149656069","media":"行情直击","labels":[],"top":1,"itemType":null,"share":"https://www.laohu8.com/m/news/1149656069?lang=zh_cn&edition=full","pubTime":"2026-07-29 09:40","pubTimestamp":1785289243,"startTime":"0","endTime":"0","summary":"7月29日,农夫山泉盘中上涨3.06%,报43.14港元,成交额3742.69万港元。消息面上,美银证券近日发布研报,指出尽管PET塑料价格同比仍上涨约20%且竞争加剧,但鉴于农夫山泉拥有稳健的营收增长前景及具韧性的利润率表现,仍将其列为中国饮料行业首选股。此外,中信建投此前亦维持公司\"增持\"评级,预计公司未来三年净利润分别同比增长16.59%、14.16%及13.07%。多家机构看好叠加估值回调后性价比凸显,股价延续前一交易日上涨势头。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"农夫山泉盘中上涨3.06%,美银证券列为中国饮料行业首选股提振延续","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09633"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188158599","title":"异动解读|农夫山泉盘中上涨3.12%,获美银证券列为中国饮料行业首选股","url":"https://stock-news.laohu8.com/highlight/detail?id=1188158599","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188158599?lang=zh_cn&edition=full","pubTime":"2026-07-28 10:12","pubTimestamp":1785204722,"startTime":"0","endTime":"0","summary":"7月28日,农夫山泉盘中上涨3.12%,报41.6港元,成交额7708.37万港元。消息面上,美银证券近日发布研报指出,尽管PET塑料价格同比仍上涨约20%且竞争加剧,但鉴于农夫山泉拥有稳健的营收增长前景及具韧性的利润率表现,仍将其列为中国饮料行业首选股。此外,中信建投此前亦维持公司\"增持\"评级,预计公司2026至2028年净利润分别同比增长16.59%、14.16%及13.07%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"农夫山泉盘中上涨3.12%,获美银证券列为中国饮料行业首选股","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09633"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654057461","title":"每周股票复盘:万泰生物(603392)RSV疫苗临床试验获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2654057461","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2654057461?lang=zh_cn&edition=full","pubTime":"2026-07-26 02:56","pubTimestamp":1785005770,"startTime":"0","endTime":"0","summary":"截至2026年7月24日收盘,万泰生物报收于28.53元,较上周的28.55元下跌0.07%。本周,万泰生物7月21日盘中最高价报29.63元。万泰生物当前最新总市值360.73亿元,在医疗器械板块市值排名4/129,在两市A股市值排名512/5200。本周关注点公司公告汇总:冻干重组RSV疫苗临床试验申请获国家药监局受理。临床前数据显示其具有良好的安全性和免疫原性。本次申请受理标志着公司重组蛋白疫苗研发取得阶段性进展,后续仍存在研发不确定性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072600000933.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK1589","BK1200","603392","09633","LU1981816686.USD","159646"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653726840","title":"万泰生物:目前公司疫苗已在全国31个省级政府官方预约平台上线","url":"https://stock-news.laohu8.com/highlight/detail?id=2653726840","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653726840?lang=zh_cn&edition=full","pubTime":"2026-07-23 21:01","pubTimestamp":1784811660,"startTime":"0","endTime":"0","summary":"证券日报网讯7月23日,万泰生物在互动平台回答投资者提问时表示,目前公司疫苗已在全国31个省级政府官方预约平台上线,如北京“京通”、上海“随申办”、浙江“浙里办”等。\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-07-23/doc-iniivazc5330538.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-07-23/doc-iniivazc5330538.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["603392","BK0239","LU1981816686.USD","BK1200","159646","09633","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653717767","title":"美银证券:中国饮料业成本压力缓解 但增长阻力犹存 农夫山泉(09633.HK)为首选","url":"https://stock-news.laohu8.com/highlight/detail?id=2653717767","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653717767?lang=zh_cn&edition=full","pubTime":"2026-07-23 15:49","pubTimestamp":1784792984,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1200","LU1981816686.USD","09633","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653716432","title":"农夫山泉(09633)跌超4.6% 美银料中国饮料业增长压力仍存","url":"https://stock-news.laohu8.com/highlight/detail?id=2653716432","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653716432?lang=zh_cn&edition=full","pubTime":"2026-07-23 13:23","pubTimestamp":1784784195,"startTime":"0","endTime":"0","summary":"金吾财讯 | 农夫山泉 股价持续受压,截至发稿,报40.92港元,跌4.62%,成交额3.27亿港元。大和研报指,预期农夫山泉上半年收入按年增长14%至292亿元人民币,纯利增长18.8%至90亿元人民币,净利润率扩张1.3个百分点至31%。展望下半年,该行表示,由于农夫山泉的比较基数较高,且利润率的不确定性将会增加,令收入增长进一步放缓至10%。该行下调农夫山泉2027至28年的每股盈测3至4%,主要是反映包装水业务复苏放缓。","market":"us","thumbnail":"https://static.szfiu.com/news/20241108/MGQ5MWNhYjgxMjA0ZDU3OGI4Y2EzYTk1OWIyNGM1NTg2NTUyNjEzMTk5Ng==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MGQ5MWNhYjgxMjA0ZDU3OGI4Y2EzYTk1OWIyNGM1NTg2NTUyNjEzMTk5Ng==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1986612","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09633","LU1981816686.USD","BK1200","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653371563","title":"港股早盘持续发力 恒指半日涨1.34% 中国铝业(02600)升7.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653371563","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653371563?lang=zh_cn&edition=full","pubTime":"2026-07-23 12:21","pubTimestamp":1784780502,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股早盘持续发力,截至午间收盘,恒指涨1.34%,国企指数涨1.32%,恒生科技指数涨0.79%。跌幅方面,农夫山泉跌4.80%,中芯国际跌3.43%,中国生物制药跌2.24%,百济神州跌1.98%,网易跌0.98%。但复盘2022年至2023年的美联储加息周期,金价在同期依旧处于上行通道,尤其在2022年12月加息力度从75bp调整为50bp之后。芯片股走低,华虹宏力跌6.44%,中芯国际跌3.43%,上海复旦跌2.09%,中兴通讯跌1.80%。按盈利指引中位数计,该行估算国泰上半年核心盈利将同比增长约33%。","market":"sh","thumbnail":"https://static.szfiu.com/news/20241108/NGJmNWFkZDNlMDY5ZTM0ZDA3ZmU4NjQzMjc2Mzg3NzYxMw==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/NGJmNWFkZDNlMDY5ZTM0ZDA3ZmU4NjQzMjc2Mzg3NzYxMw==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1986608","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1175","02833","BK1568","BK4585","BK0012","BK4588","HK0000286598.CNH","07300","HSImain","BK0028","09633","KCAI","BK1592","83115","03419","03037","BK0196","09115","LU1808992512.USD","BK0006","HSI","BK0233","02800","03115","LU1981816686.USD","07500","02600","07200","MCHmain","513600","BK0188","HHImain","MHImain","BK0010","601600","BK1513","BK1200","BK1589","BK0183","VXUS","82800"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653750791","title":"万泰生物(603392)新增【肝炎】概念","url":"https://stock-news.laohu8.com/highlight/detail?id=2653750791","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653750791?lang=zh_cn&edition=full","pubTime":"2026-07-22 20:30","pubTimestamp":1784723417,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息整理,7月22日万泰生物新增概念。万泰生物主营业务:体外诊断试剂、体外诊断仪器与疫苗的研发、生产及销售。万泰生物2026年一季报显示,一季度公司主营收入5.23亿元,同比上升30.63%;归母净利润-4298.38万元,同比上升18.56%;扣非净利润-6460.29万元,同比上升38.49%;负债率12.88%,投资收益1472.47万元,财务费用532.12万元,毛利率69.86%。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072200044353.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1589","09633","LU1981816686.USD","BK0239","603392","BK1200"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652211145","title":"万泰生物(603392)披露冻干重组呼吸道合胞病毒疫苗临床试验申请获受理公告,7月20日股价上涨2.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652211145","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652211145?lang=zh_cn&edition=full","pubTime":"2026-07-20 22:27","pubTimestamp":1784557635,"startTime":"0","endTime":"0","summary":"截至2026年7月20日收盘,万泰生物报收于29.24元,较前一交易日上涨2.42%,最新总市值为369.71亿元。该股当日开盘28.46元,最高29.49元,最低28.4元,成交额达2.25亿元,换手率为0.61%。近日,万泰生物发布关于公司冻干重组呼吸道合胞病毒疫苗临床试验申请获得受理的公告。临床前数据显示其具有良好的安全性和免疫原性。本次申请受理标志着公司重组蛋白疫苗研发取得阶段性进展,后续仍存在研发不确定性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072000039723.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1981816686.USD","09633","BK0239","BK1200","603392","BK1589","159646"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652652492","title":"万泰生物荣获证券之星负责任供应链奖","url":"https://stock-news.laohu8.com/highlight/detail?id=2652652492","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652652492?lang=zh_cn&edition=full","pubTime":"2026-07-20 09:21","pubTimestamp":1784510472,"startTime":"0","endTime":"0","summary":"北京万泰生物药业股份有限公司凭借在可持续供应链管理及负责任采购领域的突出实践,荣获\"ESG负责任供应链奖\"。该奖项由证券之星联合华证指数共同开展,自2023年首届以来已连续举办四届。制度护航:以合规治理筑牢供应链根基治理层面,万泰生物建立了四级ESG治理架构,2025年度公司董事会由9人组成,含独董3名、女性董事2名。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2026072000003337.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1200","09633","603392","LU1981816686.USD","161027","BK1589","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652252730","title":"股市必读:万泰生物(603392)7月17日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2652252730","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652252730?lang=zh_cn&edition=full","pubTime":"2026-07-20 01:36","pubTimestamp":1784482569,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘,万泰生物报收于28.55元,下跌4.52%,换手率0.64%,成交量8.11万手,成交额2.36亿元。董秘最新回复投资者: 关于邀请钟老重返公司董事会任职和将养生堂核心资产注入上市公司,合二为一,彻底解决同业竞争的建议,希望公司管理层高度重视并尽快落实。公司管理层将持续深耕主业维护全体股东长期利益。如有相关方案落地,公司将依规及时披露公告。被寄予厚望的九价上市一年中报依然亏损。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072000000796.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1589","09633","BK1200","LU1981816686.USD","603392","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652423052","title":"每周股票复盘:万泰生物(603392)上半年净利预亏1.16亿至1.4亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2652423052","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652423052?lang=zh_cn&edition=full","pubTime":"2026-07-19 02:32","pubTimestamp":1784399531,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘,万泰生物报收于28.55元,较上周的28.74元下跌0.66%。本周,万泰生物7月17日盘中最高价报30.33元。本周关注点业绩披露要点:万泰生物预计2026年上半年归属净利润亏损1.16亿元至1.4亿元。业绩披露要点万泰生物发布业绩预告,预计2026年1-6月扣非后净利润亏损1.5亿元至1.86亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071900000762.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1981816686.USD","603392","09633","BK1589","BK1200","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652231538","title":"开塞露配东方树叶可减重8斤?农夫山泉官方客服:没有这个喝法,别乱喝!","url":"https://stock-news.laohu8.com/highlight/detail?id=2652231538","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652231538?lang=zh_cn&edition=full","pubTime":"2026-07-18 15:59","pubTimestamp":1784361540,"startTime":"0","endTime":"0","summary":"7月18日,近日,一则“开塞露搭配东方树叶饮用可快速减重8斤”的减肥偏方在社交平台上流传。不少博主跟风拍摄兑服视频。\n 一条点赞最高的相关短视频显示,一名网友将两瓶开塞露开封后,全部挤入茶饮内,摇晃后喝尽。文案宣称“东方树叶+开塞露,两天能瘦8斤”。面对评论区网友“管用吗”的追问,该博主回应称“刚喝上,还没啥反应”,并坦言自己也只是照做,估计没啥效果。\n 对于“该配方是否有用”,截至发稿前农夫山泉官方暂无回应;官方旗舰店客服则向新浪财经明确表示:“没有这个喝法”,并反复强调:“身体重要,不要乱喝”。\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:凌辰","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-07-18/doc-iniifhtw7121576.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["09633","BK1589","LU1981816686.USD","BK1200"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652402829","title":"万泰生物:由股东以个人资金自发设立扶助基金属于股东自主公益行为","url":"https://stock-news.laohu8.com/highlight/detail?id=2652402829","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652402829?lang=zh_cn&edition=full","pubTime":"2026-07-17 18:15","pubTimestamp":1784283313,"startTime":"0","endTime":"0","summary":"证券之星消息,万泰生物07月17日在投资者关系平台上答复投资者关心的问题。感谢您饱含公益初心的宝贵建议,公司尊重各位股东的公益意愿,由股东以个人资金自发设立扶助基金属于股东自主公益行为,不属于公司可决策推进事项。公司自身也持续通过公益捐赠、普惠推广、扩大产能等方式提升疫苗接种可及性,助力宫颈癌防控工作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700034089.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603392","BK1200","09633","LU1981816686.USD","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652040282","title":"万泰生物:该方案存在多项合规约束","url":"https://stock-news.laohu8.com/highlight/detail?id=2652040282","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652040282?lang=zh_cn&edition=full","pubTime":"2026-07-17 18:15","pubTimestamp":1784283304,"startTime":"0","endTime":"0","summary":"证券之星消息,万泰生物07月17日在投资者关系平台上答复投资者关心的问题。感谢您心系宫颈癌防控并提出宝贵试点建议。该方案存在多项合规约束。公司后续会持续丰富学术数据、拓展海内外市场、优化渠道运营,稳步提升九价HPV疫苗市场销量与品牌影响力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700034077.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1589","LU1981816686.USD","603392","09633","BK1200","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652015404","title":"万泰生物:公司与关联方进行业务边界划分","url":"https://stock-news.laohu8.com/highlight/detail?id=2652015404","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652015404?lang=zh_cn&edition=full","pubTime":"2026-07-17 18:12","pubTimestamp":1784283179,"startTime":"0","endTime":"0","summary":"证券之星消息,万泰生物07月17日在投资者关系平台上答复投资者关心的问题。公司与关联方进行业务边界划分,主要为履行上市承诺、落实监管对同业竞争的治理规范,切实维护上市公司及中小股东合法权益。感谢您对公司的关注。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700033936.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1981816686.USD","BK1200","BK1589","603392","09633","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652040144","title":"万泰生物:统筹研究股权激励相关安排","url":"https://stock-news.laohu8.com/highlight/detail?id=2652040144","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652040144?lang=zh_cn&edition=full","pubTime":"2026-07-17 18:12","pubTimestamp":1784283178,"startTime":"0","endTime":"0","summary":"证券之星消息,万泰生物(603392)07月17日在投资者关系平台上答复投资者关心的问题。投资者提问:董事长好,公司拨乱反正,相信在您的带领下,公司能再现辉煌。但还是认为公司需要给将来的管理层实施点股权激励为好!同心同德,共同努力把公司各项业务做好。万泰生物回复:您好!感谢您的肯定与建议。公司十分重视长效激励机制建设,后续将结合公司经营情况、监管规则统筹研究面向管理团队及核心人员的股权激励相关安排,充分凝聚团队力量助力公司发展。如有相关方案落地,公司将依规及时披露公告。感谢您对公司的关注。本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700033931.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1589","603392","09633","LU1981816686.USD","BK0239","BK1200"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652040184","title":"万泰生物:后续将策划适配的宣传与公益科普活动","url":"https://stock-news.laohu8.com/highlight/detail?id=2652040184","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652040184?lang=zh_cn&edition=full","pubTime":"2026-07-17 18:12","pubTimestamp":1784283164,"startTime":"0","endTime":"0","summary":"证券之星消息,万泰生物07月17日在投资者关系平台上答复投资者关心的问题。感谢您对公司九价HPV疫苗产品的认可与宝贵建议。公司现阶段持续通过学术推广、大众科普、渠道落地等方式提升产品国民认知度,后续将根据疫苗实际接种规模与品牌整体推广计划,策划适配的宣传与公益科普活动,进一步彰显国产疫苗自主研发成果,扩大国货产品影响力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700033916.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1589","09633","BK0239","BK1200","LU1981816686.USD","603392"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652040654","title":"万泰生物:董事长代行总经理、董事会秘书职责","url":"https://stock-news.laohu8.com/highlight/detail?id=2652040654","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652040654?lang=zh_cn&edition=full","pubTime":"2026-07-17 18:12","pubTimestamp":1784283143,"startTime":"0","endTime":"0","summary":"证券之星消息,万泰生物07月17日在投资者关系平台上答复投资者关心的问题。核心经营、资本、投资者关系长期由邱子欣一人代管,是否存在管理效率不足风险?公司将按照相关规定,尽快完成总经理、董事会秘书的选聘工作并及时履行信息披露义务。公司管理层将持续深耕主业维护全体股东长期利益。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700033890.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1589","603392","BK1200","BK0239","LU1981816686.USD","09633"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.nongfuspring.com","stockEarnings":[{"period":"1week","weight":-0.0137},{"period":"1month","weight":-0.016},{"period":"3month","weight":-0.1079},{"period":"6month","weight":-0.1366},{"period":"1year","weight":-0.0491},{"period":"ytd","weight":-0.0824}],"compareEarnings":[{"period":"1week","weight":0.0071},{"period":"1month","weight":0.1164},{"period":"3month","weight":-0.0307},{"period":"6month","weight":-0.095},{"period":"1year","weight":-0.0098},{"period":"ytd","weight":-0.0125}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"农夫山泉股份有限公司是一家主要从事生产及销售包装饮用水及饮料的中国公司。该公司通过五个分部运营。水类产品分部从事制造及销售天然包装饮用水。即饮茶类产品分部从事制造及销售即饮茶。功能饮料产品分部从事制造及销售功能饮料。果汁饮料产品分部从事制造及销售果汁饮料产品。其他产品分部从事制造及销售农产品及其他饮料。该公司主要在国内市场开展其业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.003567},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.016331},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.07575},{"month":4,"riseRate":0.666667,"avgChangeRate":0.026458},{"month":5,"riseRate":0.666667,"avgChangeRate":0.019912},{"month":6,"riseRate":0.5,"avgChangeRate":-0.035833},{"month":7,"riseRate":0.833333,"avgChangeRate":0.021581},{"month":8,"riseRate":0.4,"avgChangeRate":0.006063},{"month":9,"riseRate":0.6,"avgChangeRate":0.047998},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.055387},{"month":11,"riseRate":0.833333,"avgChangeRate":0.094346},{"month":12,"riseRate":0.666667,"avgChangeRate":0.06968}],"exchange":"SEHK","name":"农夫山泉","nameEN":"NONGFU SPRING"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"农夫山泉(09633)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供农夫山泉(09633)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"农夫山泉,09633,农夫山泉股票,农夫山泉股票老虎,农夫山泉股票老虎国际,农夫山泉行情,农夫山泉股票行情,农夫山泉股价,农夫山泉股市,农夫山泉股票价格,农夫山泉股票交易,农夫山泉股票购买,农夫山泉股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"农夫山泉(09633)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供农夫山泉(09633)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}